10-K Filing

KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC CIK: 1730430 FY 2018

Filing Information

Form Type	10-K
Accession Number	`0001558370-19-001857`
Period End Date	20181231
Filing Date	20190312
Fiscal Year	2018
Fiscal Period	FY
XBRL Instance	knsa-20181231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 48 Income Statement 26 Cash Flow Statement 45 Stockholders Equity 18

Balance Sheet 48 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, shares issued (in shares)	`TemporaryEquitySharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`TemporaryEquitySharesIssued`	22.89M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$71.98M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$45.55M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`TemporaryEquitySharesOutstanding`	22.89M	shares	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$105.00K	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$235.33M	USD	Point-in-time
Preferred stock, aggregate liquidation preference	`TemporaryEquityLiquidationPreference`	$120.00M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.44M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.45M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$313.75M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$47.10M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.36M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$125.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$210.00K	USD	Point-in-time
Deferred offering costs	`DeferredCosts`	$433.00K	USD	Point-in-time
Deferred offering costs	`DeferredCosts`	$25.00K	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$1.22M	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$238.00K	USD	Point-in-time
Total assets	`Assets`	$321.96M	USD	Point-in-time
Total assets	`Assets`	$47.49M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.92M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.22M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$16.42M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$6.21M	USD	Point-in-time
Accrued milestones	`AccruedMilestoneLiabilitiesCurrent`	$15.00M	USD	Point-in-time
Accrued milestones	`AccruedMilestoneLiabilitiesCurrent`	$10.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$218.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$42.55M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$17.43M	USD	Point-in-time
Deferred rent	`AccruedRentNoncurrent`	$144.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$17.43M	USD	Point-in-time
Total liabilities	`Liabilities`	$42.70M	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible preferred shares (Series A, B and C), $0.000273235 par value; 0 shares and 22,885,492 shares issued and outstanding as of December 31, 2018 and December 31, 2017, respectively; aggregate liquidation preference of $0 and $120,000 as of December 31, 2018 and December 31, 2017, respectively;	`TemporaryEquityCarryingAmountAttributableToParent`	$119.77M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.29M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$473.48M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-4.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-91.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-194.22M	USD	Point-in-time
Total shareholders equity (deficit)	`StockholdersEquity`	$-25.73M	USD	Point-in-time
Total shareholders equity (deficit)	`StockholdersEquity`	$279.27M	USD	Point-in-time
Total shareholders equity (deficit)	`StockholdersEquity`	$-89.71M	USD	Point-in-time
Total liabilities, convertible preferred shares and shareholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$321.96M	USD	Point-in-time
Total liabilities, convertible preferred shares and shareholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$47.49M	USD	Point-in-time

Income Statement 26 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$86.60M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$56.36M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$9.04M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$21.56M	USD	Annual
Total operating expenses	`OperatingExpenses`	$65.40M	USD	Annual
Total operating expenses	`OperatingExpenses`	$108.16M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-65.40M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-108.16M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$529.00K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$4.72M	USD	Annual
Loss before benefit (provision) for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-64.87M	USD	Annual
Loss before benefit (provision) for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-103.44M	USD	Annual
Benefit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$2.00K	USD	Annual
Benefit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$-214.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-64.87M	USD	Annual
Net loss	`NetIncomeLoss`	$-103.23M	USD	Annual
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-35.85	USD	Annual
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-3.49	USD	Annual
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	29.55M	shares	Annual
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.81M	shares	Annual
Net loss	`NetIncomeLoss`	$-64.87M	USD	Annual
Net loss	`NetIncomeLoss`	$-103.23M	USD	Annual
Unrealized loss on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-4.00K	USD	Annual
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-4.00K	USD	Annual
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-64.87M	USD	Annual
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-103.23M	USD	Annual

Cash Flow Statement 45 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-103.23M	USD	Annual
Net loss	`ProfitLoss`	$-64.87M	USD	Annual
Depreciation expense	`Depreciation`	$286.00K	USD	Annual
Depreciation expense	`Depreciation`	$28.00K	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$5.70M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$897.00K	USD	Annual
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-66.00K	USD	Annual
Non-cash rent expense	`NonCashRentExpense`	$235.00K	USD	Annual
Accretion of discounts on short-term investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.42M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-197.00K	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-978.00K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$4.79M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.19M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$8.82M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.01M	USD	Annual
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$9.30M	USD	Annual
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$4.11M	USD	Annual
Accrued milestone	`IncreaseDecreaseInAccruedMilestone`	$5.00M	USD	Annual
Accrued milestone	`IncreaseDecreaseInAccruedMilestone`	$10.00M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-50.22M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-81.01M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.29M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$69.00K	USD	Annual
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$402.01M	USD	Annual
Proceeds from the maturities of short-term investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments`	$168.10M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-69.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-239.20M	USD	Annual
Proceeds from issuance of Class A common shares upon completion of initial public offering, net of underwriting commissions and discounts	`ProceedsFromIssuanceOfCommonStock`	$82.97M	USD	Point-in-time
Payments of offering costs	`PaymentsOfStockIssuanceCosts`	$3.66M	USD	Annual
Proceeds from exercise of options and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$377.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$39.87M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$346.74M	USD	Annual
Net increase (decrease) in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$26.53M	USD	Annual
Net increase (decrease) in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-10.41M	USD	Annual
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.19M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$45.66M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$56.08M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.19M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$45.66M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$56.08M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$383.00K	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	$290.00K	USD	Annual
Deferred offering costs included in accrued expenses and accounts payable	`DeferredOfferingCostsIncludedInAccruedExpensesAndAccountsPayable`	$404.00K	USD	Annual
Deferred offering costs included in accrued expenses and accounts payable	`DeferredOfferingCostsIncludedInAccruedExpensesAndAccountsPayable`	$25.00K	USD	Annual
Property and equipment included in accrued expenses and accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$1.29M	USD	Annual

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of the period	`TemporaryEquityCarryingAmountAttributableToParent`	$119.77M	USD	Point-in-time
Balance at the beginning of the period (in shares)	`TemporaryEquitySharesOutstanding`	22.89M	shares	Point-in-time
Balance at the end of the period	`TemporaryEquityCarryingAmountAttributableToParent`	$119.77M	USD	Point-in-time
Balance at the end of the period (in shares)	`TemporaryEquitySharesOutstanding`	22.89M	shares	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$-25.73M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$279.27M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$-89.71M	USD	Point-in-time
Conversion of convertible preferred shares into common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$310.59M	USD	Annual
Issuance of Class A common shares upon completion of initial public offering, net of underwriting discounts and commissions and offering costs	`StockIssuedDuringPeriodValueNewIssues`	$155.54M	USD	Annual
Exercise of options and issuance of shares under the employee share purchase plan	`StockIssuedDuringPeriodValueStockOptionsExercised`	$377.00K	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.70M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$897.00K	USD	Annual
Unrealized loss on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-4.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-64.87M	USD	Annual
Net loss	`NetIncomeLoss`	$-103.23M	USD	Annual
Balance at the end of the period	`StockholdersEquity`	$-25.73M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$279.27M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$-89.71M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.